编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
---|---|---|---|---|
90731 | GDC-0810 ( Brilanestrant , ARN-810 ) | 1365888-06-7 | ≧98.0% | |
GDC-0810 (Brilanestrant, ARN-810, RG6046) is a selective estrogen receptor degrader ( | ||||
102703 | AZD-8835 | 1620576-64-8 | ≧98.0% | |
AZD8835 is a potent and selective inhibitor ofPI3KαandPI3KδwithIC50s of 6.2 and 5.7 | ||||
611902 | PF-04979064 | 1220699-06-8 | ≧98.0% | |
PF-04979064 is a potent and selective PI3K/mTOR dual kinase inhibitor with an IC(50) | ||||
6111110 | Nastorazepide | 209219-38-5 | 98% | |
Nastorazepide (Z-360) is a selective, orally available, 1,5-benzodiazepine-derivative | ||||
174192 | RG7800 ( RO6885247 ) | 1449598-06-4 | ≧98.0% | |
RG7800(RO6885247)是一种小分子改变生存运动神经元2的拼接。 | ||||
90734 | RSM932A | 850807-63-5 | ≧98.0% | |
Choline kinase α (CHKA; here designated as ChoKα) is the first enzyme in the CDP-ch | ||||
184321 | Ensartinib ( X396 ) | 1370651-20-9 | >98% | |
Ensartinib is an orally available small molecule inhibitor of the receptor tyrosine k | ||||
185235 | Trilaciclib (G1T28) | 1374743-00-6 | >98% | |
Trilaciclib是一种小分子竞争性细胞周期蛋白依赖性激酶4和6(CDK4 / | ||||
188281 | Arimoclomol maleate | 289893-26-1 | 98% | |
Arimoclomol,也被称为BRX-220,能够潜在有用的治疗Niemann-Pick疾病C型 | ||||
1811162 | PF-05231023 | 1037589-69-7 | >98% | |
PF-05231023是一种长效FGF21仿生产品。PF-05231023可以减轻非人类灵长类 | ||||
1811211 | Anlotinib HCl ( AL-3818 ) | 1360460-82-7 | ≧98.0% | |
Anlotinib也被称为AL3818,是一种受体酪氨酸激酶(RTK)抑制剂,具有潜 | ||||
191122 | Tafenoquine ( 他非诺喹 ) | 106635-80-7 | ≧98.0% | |
Tafenoquine is being investigated as a potential treatment for malaria, as well as fo |